ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 226

$426K Total Retail Price of All Prescriptions

Rank: 80 out of 226

291 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 291 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 7,474 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $106 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 446 364 1 1
SIMVASTATIN 415 346 2 10
LEVOTHYROXINE SODIUM 323 252 3 18
LISINOPRIL 303 257 4 3
ATENOLOL 289 265 5 32
HYDROCHLOROTHIAZIDE 252 218 6 20
OMEPRAZOLE 250 195 7 16
FUROSEMIDE 221 174 8 2
RANITIDINE HCL 200 171 9 47
POTASSIUM CHLORIDE 199 188 10 25
METFORMIN HCL 180 140 11 39
FLUTICASONE PROPIONATE 168 131 12 76
CARVEDILOL 140 75 13 7
METOPROLOL TARTRATE 138 112 14 9
ENALAPRIL MALEATE 138 117 14 69
GABAPENTIN 137 130 16 21
CLOPIDOGREL 127 121 17 44
HYDRALAZINE HCL 124 90 18 5
PRAVASTATIN SODIUM 123 104 19 30
HYDROCODONE-ACETAMINOPHEN 120 75 S3 20 17
WARFARIN SODIUM 119 102 21 37
GLYBURIDE 114 100 R 22 106
NEXIUM 113 69 23 26
CLONIDINE HCL 112 71 24 12
METOPROLOL SUCCINATE 105 104 25 22
PLAVIX 99 96 26 64
GLIMEPIRIDE 92 77 27 51
LOSARTAN POTASSIUM 87 74 28 13
SERTRALINE HCL 84 66 29 67
ZOLPIDEM TARTRATE 77 77 30 29
ATORVASTATIN CALCIUM 74 68 31 27
CALCIUM ACETATE 74 64 31 14
MELOXICAM 74 59 31 77
CITALOPRAM HBR 71 71 34 52
ALLOPURINOL 69 63 35 11
CIPROFLOXACIN HCL 65 58 36 59
TRAMADOL HCL 63 60 37 28
AMOXICILLIN 62 49 38 133
LANTUS 61 48 39 53
TAMSULOSIN HCL 60 48 40 46
CRESTOR 59 59 41 42
INSULIN SYRINGE 58 53 42 54
TERAZOSIN HCL 57 45 43 56
DONEPEZIL HCL 53 53 44 79
PREDNISONE 52 25 45 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.